✦ LIBER ✦

Open trials in colorectal cancer

✍ Scribed by Lars Phlman

Book ID: 117569277
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 509 KB
Volume: 21
Category: Article
ISSN: 0748-7983
DOI: 10.1016/s0748-7983(95)92186-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adhesions and incisional hernias followi

Adhesions and incisional hernias following laparoscopic versus open surgery for colorectal cancer in the CLASICC trial

✍ G. W. Taylor; Mr D. G. Jayne; S. R. Brown; H. Thorpe; J. M. Brown; S. C. Dewberr 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

Chemotherapy options in elderly and frai

Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial

✍ Matthew T Seymour; Lindsay C Thompson; Harpreet S Wasan; Gary Middleton; Alison 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 308 KB

Figitumumab in patients with refractory

Figitumumab in patients with refractory metastatic colorectal cancer previously treated with standard therapies: a nonrandomized, open-label, phase II trial

✍ Becerra, Carlos R.; Salazar, Ramon; Garcia-Carbonero, Rocio; Thomas, Anne L.; Vá 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 273 KB

OP26. Assessing the relative costs of st

OP26. Assessing the relative costs of standard open surgery and laparoscopic surgery in colorectal cancer in a randomised controlled trial

✍ ML Stead; JM Brown; PJ Franks; N Bosanquet; PJ Guillou; P Quirke; D Jayne; AV We 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 344 KB

An Open-label, Single-arm, Phase 2 Trial

An Open-label, Single-arm, Phase 2 Trial of Panitumumab Plus FOLFIRI as Second-line Therapy in Patients with Metastatic Colorectal Cancer

✍ Allen L. Cohn; Grace C. Shumaker; Pankaj Khandelwal; David A. Smith; Marcus A. N 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 429 KB

Bevacizumab plus capecitabine versus cap

Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial

✍ Cunningham, David; Lang, Istvan; Marcuello, Eugenio; Lorusso, Vito; Ocvirk, Janj 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 367 KB